Recent advances in glucose oxidase-based nanocarriers for tumor targeting therapy.

Li, Su; Wang, Qinghua; Jia, Zhen; Da, Mengting; Zhao, Jiuda; Yang, Rui; Chen, Daozhen

Li, Su; Wang, Qinghua; Jia, Zhen; Da, Mengting; Zhao, Jiuda; Yang, Rui; Chen, Daozhen.

Afiliación

Li S; Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Hospital of Nanjing Medical University, Wuxi, 214002, China.
Wang Q; Wuxi Maternal and Child Health Hospital, Wuxi School of Medicine, Jiangnan University, Jiangsu, 214002, China.
Jia Z; Department of Obstetrics and Gynecology, Haidong No. 2 People's Hospital, Haidong, 810699, China.
Da M; Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University and Affiliated Cancer Hospital of Qinghai University, Xining, 810001, China.
Zhao J; Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University and Affiliated Cancer Hospital of Qinghai University, Xining, 810001, China.
Yang R; Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Hospital of Nanjing Medical University, Wuxi, 214002, China.
Chen D; Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Hospital of Nanjing Medical University, Wuxi, 214002, China.

Heliyon ; 9(10): e20407, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37780773

Palabras clave

Cancer; Glucose oxidase; Nanocarriers; Targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Heliyon Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google